First US Part III trial for COVID-19 vaccine begins

Enlarge / A analysis affiliate works on the Moderna Therapeutics Inc. lab in Cambridge, Massachusetts. (credit score: Bloomberg/Getty Photographs) Moderna has given the primary doses of its experimental COVID-19 vaccine to contributors in what shall be a 30,000-person trial, as

Read More »